Implementation of a smoking cessation protocol in dental practices

ISRCTN ISRCTN19783832
DOI https://doi.org/10.1186/ISRCTN19783832
Secondary identifying numbers NTR614
Submission date
04/04/2006
Registration date
04/04/2006
Last edited
18/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J.E. Jacobs
Scientific

University Medical Center St Radboud
Center for Quality of Care Research (WOK)
P.O. Box 9101
Nijmegen
6500 HB
Netherlands

Phone +31 (0)24 3615310
Email j.jacobs@kwazo.umcn.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Scientific title
Study acronymTAPS
Study objectivesThe intervention increases advice given by dental professionals, the number of patients having quit smoking and the number of quit attempts.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedTobacco addiction
InterventionProvision of a 4 hour central course for whole practice teams, patient-mediated monitoring and feedback of the provision of cessation advice, patient education materials and a task organisation protocol for the various members of the dental team.
The dental teams in the control group deliver usual care.
Intervention typeOther
Primary outcome measurePatient-reported number of smoking cessation advice given by the dental team, patients' smoking status and quit attempts.
Secondary outcome measuresProfessionals' attitudes towards smoking and smoking cessation support, their knowledge of health consequences of smoking tobacco (especially dental health), patients' perspectives of smoking cessation.
Support by dentists will be measured as well as self-efficacy to provide smoking cessation support.
Overall study start date01/01/2006
Completion date01/11/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants1300
Key inclusion criteriaSmoking patients visiting dental practices.
Key exclusion criteriaPatients under the age of 18.
Date of first enrolment01/01/2006
Date of final enrolment01/11/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Center St Radboud
Nijmegen
6500 HB
Netherlands

Sponsor information

University Medical Center St Radboud, Center for Quality of Care Research (WOK) (The Netherlands)
Not defined

117 KWAZO
P.O. Box 9101
Nijmegen
6500 HB
Netherlands

ROR logo "ROR" https://ror.org/05wg1m734

Funders

Funder type

Industry

Pfizer (Netherlands)
Government organisation / For-profit companies (industry)
Alternative name(s)
Pfizer Inc., Pfizer Consumer Healthcare, Davis, Charles Pfizer & Company, Warner-Lambert, King Pharmaceuticals, Wyeth Pharmaceuticals, Seagen
Location
United States of America

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan